How to Invest Smart in AI for Healthcare?
How to Invest Smart in AI for Healthcare?
Artificial Intelligence is no longer a distant concept in healthcare—it is already being applied across diagnostics, operations, and patient management. The real question for healthcare leaders today is not whether to invest in AI, but how to do it in a way that delivers real value.
AI is an Enabler, Not a Replacement
AI in healthcare is no longer something to watch from a distance. It is already woven into how care is delivered, managed, and scaled across many parts of the system. What makes it interesting is not just the technology itself, but how it quietly solves very real, everyday problems in healthcare.
One of the earliest and most visible areas is imaging and diagnostics. For more than a decade, AI has been helping analyze X rays, ultrasounds, CT scans, and MRIs to detect small lesions that are easy to miss. In tuberculosis screening, for example, AI can flag abnormal patterns quickly and consistently. More advanced solutions like Harrison.ai can read a brain scan and generate a preliminary report in about 90 seconds, compared to the 20 minutes it might take a radiologist.
Another area that is gaining traction is clinical documentation. AI tools are now being used to support and automate this process, making records more accurate and easier to manage. Health systems like Mass General Brigham in the US have started using AI to reduce administrative burden, helping doctors spend more time with patients instead of paperwork.
AI is also making a difference in early warning systems, where timing can change outcomes completely. A well-known example is the sepsis early warning system developed by John’s Hopkins Hospital. It continuously monitors clinical and biochemical data, alerting physicians before a patient’s condition becomes critical.
Beyond direct patient care, AI is quietly transforming operations. Areas like revenue cycle management, insurance claims processing, and patient flow are highly process driven and often inefficient. AI can streamline these workflows, reduce errors, and improve financial performance. Some hospitals in the US are already using AI to automate claims processing. In Vietnam, Bach Mai Hospital has applied AI to manage patient movement and insurance workflows and has reported measurable improvements.
A newer but fast-growing space is chronic disease management. Platforms like Lillia which is part of Axel’s digital key AI partner for chronic disease management in Asia, are combining doctor guidance with AI driven predictions to help patients manage weight, blood sugar, and lifestyle changes. With over 1.5 million users across four countries, Lillia shows how AI can extend care beyond hospitals. Vietnam has been selected as a pilot market, largely because of its complex disease patterns and gaps in access to continuous care.
At the system level, many countries are moving toward nationwide electronic medical records as a foundation for AI. Vietnam’s Ministry of Health is taking steps in this direction, aiming to standardize EMRs and develop AI models for diagnosis and early detection. Without structured and scalable data, AI simply cannot deliver its full potential.
From Impact to Implementation
AI improves efficiency by automating repetitive tasks like documentation and claims, freeing up time for patient care while making data more structured and performance easier to measure. In markets with workforce shortages, it also supports early interactions and triage. Financially, it reduces reliance on manual resources and improves claims processing. Beyond that, it eases the burden on doctors, enhances care consistency, and expands access — delivering both measurable and meaningful impact.
However, moving from impact to implementation is where complexity begins.
Healthcare is fundamentally human. AI can support decisions, but trust, communication, and clinical judgment remain essential — especially in complex cases. At the same time, fragmented systems, and uneven digital maturity, particularly across Asia, make integration difficult. Many solutions also require localization, while implementation demands significant investment in infrastructure, processes, and people. Adoption is equally critical — AI must fit naturally into workflows and clearly improve the day-to-day experience for doctors. Regulation adds another layer, requiring strict validation of safety and outcomes. This can slow deployment but is necessary to build trust.
Given these realities, implementation rarely starts with large-scale transformation. It starts small — through pilot programs that allow organizations to test, refine, and scale safely.
The most effective approach is to treat AI as an augmentation layer, not a replacement. Healthcare will likely evolve through hybrid models, where digital and traditional practices coexist and improve over time. This requires patience. Transformation depends on training, alignment, and time — especially in systems shaped by national priorities.
In the end, the focus should remain on solving real problems. AI should not be deployed for the sake of innovation, but to address specific operational or clinical challenges. That is where the shift from impact to implementation truly happens — not in the technology itself, but in how intentionally it is applied.